- The wording
- BBC World News
US health authorities gave the green light Friday to resume use of the Johnson & Johnson (J&J) Janssen covid-19 vaccine, but requested that recipients be informed of the possibility of extremely rare blood clots forming.
The Centers for Disease Control and Prevention (CDC) said in a previous statement that “the use of the vaccine must be resumed in the United States” and that they are “confident that this vaccine is safe and effective in preventing Covid-19.”
They added that “Blood clots or blood clots are very rare.”.
Medical staff and doses should review the vaccine fact sheet […], Which includes information about the risks of this syndrome [de formación de coágulos]That has happened in a very small number of people who have had it. “
The United States stopped using the single-dose injection in mid-April due to some reports of blood clots in the brain among women after receiving the vaccine.
In that country, 15th futureaS from dose sufferAaronfrom Dangerouss clots Of blood, Is among the nearly eight million people who have been injected since the regulatory approval of the vaccine in February.
All of them were women, and the majority were under the age of 50. Three died and seven are still in hospital.
US health authorities said Friday that it is important for women to be informed of the potential risks of the vaccine so that they can decide whether to pursue other alternatives.
Dr. Sarah Long, of Drexel University School of Medicine in Philadelphia, was among the CDC panelists who voted against resuming the use of the J&J vaccine because they believed there was not enough warning about the risks to women.
“This is the age group that is most at risk [de sufrir coágulos de sangre] He said she often gets vaccinated to save other people’s lives and illness, not her own. And I think we have a responsibility to make sure they know that.
this week, Health authorities in Europe, too They raised Restrictions ontoaSerum De J&J.
European regulators have also linked similar and very unusual blood clots to the AstraZeneca vaccine, but similarly concluded that the benefits of the injection outweigh any risks.
Remember that You can receive push notifications from BBC Mondo. Download and activate our app so that you don’t miss out on our best content.